Related Experiment Video
Updated: May 13, 2026
14:06
Mapping Bacterial Functional Networks and Pathways in Escherichia Coli using Synthetic Genetic Arrays
Published on: November 12, 2012
Stochastic modeling of systems mapping in pharmacogenomics
Zuoheng Wang1, Jiangtao Luo, Guifang Fu
1Department of Biostatistics, Yale University, New Haven, CT 06520, USA. zuoheng.wang@yale.edu
Advanced Drug Delivery Reviews
|March 27, 2013
Summary
Pharmacogenetics and pharmacogenomics research for personalized medicine benefits from dynamic modeling. Stochastic differential equations enhance systems mapping for complex drug responses, offering a computational tool for genetic studies.
Area of Science:
- Pharmacogenomics and Systems Biology
- Computational Biology and Bioinformatics
Background:
- Pharmacogenetics and pharmacogenomics are crucial for personalized medicine, requiring dynamic models of drug absorption, transport, and effects.
- Current systems mapping uses ordinary differential equations, which may not fully capture the complexity of drug response.
Purpose of the Study:
- To extend systems mapping for pharmacogenomics by incorporating stochastic differential equations (SDE).
- To provide a computational framework for analyzing complex and heterogeneous drug response patterns.
Main Methods:
- Implementation of stochastic differential equations (SDE) within the systems mapping framework.
- Modeling the dynamic processes of drug absorption, distribution, metabolism, and excretion (ADME) and drug-target interactions.
Main Results:
- SDE-implemented systems mapping allows for the analysis of more complex and heterogeneous drug response variability.
- Demonstrated the utility of SDE in capturing inherent randomness in biological systems affecting drug response.
Conclusions:
- Stochastic differential equations offer a powerful computational tool for advancing pharmacogenetic and pharmacogenomic research.
- SDE-based systems mapping is a promising approach for personalized medicine by better predicting individual drug responses.
Related Concept Videos
01:14Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model
The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A higher...
01:20Pharmacokinetic Models: Overview
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:26Pharmacokinetic Models: Comparison and Selection Criterion
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...